Related Experiment Videos
Pyodera gangrenosum after aortic valve replacement.
M Rothenburger1, T D Tjan, C Schmid
1Department of Cardiothoracic Surgery, Westfalian Wilhelms-University, Muenster, Germany. markus.rothenburger@thgms.uni-muenster.de
The Annals of Thoracic Surgery
|February 24, 2001
Summary
Pyoderma gangrenosum, a severe skin condition, can complicate cardiac surgery. Prompt treatment with steroids, clofazimine, and immunosuppressants led to complete recovery in a patient after aortic valve replacement.
Area of Science:
- Cardiovascular Surgery
- Dermatology
- Wound Healing
Background:
- Pyoderma gangrenosum (PG) is a rare, ulcerative inflammatory skin condition.
- PG can present as a severe complication following cardiac surgery, impacting wound healing.
- Cardiac surgery patients with impaired wound healing require careful monitoring for potential PG development.
Purpose of the Study:
- To report a case of pyoderma gangrenosum following elective aortic valve replacement.
- To describe the successful management of post-cardiac surgery PG.
- To highlight the importance of considering PG in cardiac surgery patients with wound healing complications.
Main Methods:
- A 68-year-old male patient underwent elective aortic valve replacement.
- Initial treatment involved steroids and clofazimine for the necrotic process.
- Surgical debridement, sternal stabilization, and wound closure were performed.
- Postoperative immunosuppression with cyclosporine A was administered.
Main Results:
- Rapid cessation of the necrotic process was achieved with initial medical treatment.
- Surgical intervention addressed thoracic instability and facilitated wound healing.
- Complete recovery was observed after the addition of cyclosporine A.
- The patient experienced full resolution of pyoderma gangrenosum and surgical wounds.
Conclusions:
- Pyoderma gangrenosum is a critical, potentially life-threatening complication after cardiac operations.
- Early recognition and a multimodal treatment approach are essential for managing post-surgical PG.
- Aggressive management including immunosuppression can lead to favorable outcomes in affected patients.